LabCorp Extends Offer for Orchid Cellmark

LabCorp extended the offer for 30 days while the FTC continues its review of the $85.4 million acquisition.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories